ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1455

IL1β mRNA Expressions in Peripheral Blood Mononuclear Cells Increase and May Associate with Cartilage Damage of the Respiratory Tract Probably Through Matrix metalloproteinase-3 Production in Patients with Relapsing Polychondritis

Jun Shimizu1, Sueshige Wakisaka1, Tomoko Suzuki1 and Noboru Suzuki2, 1St. Marianna University School of Medicine, Kawasaki, Japan, 2St. Marianna University School of Medicine, Kawasaki Kanagawa, Japan

Meeting: ACR Convergence 2021

Keywords: chondrocyte, cytokines, Inflammation, Metalloproteinase, Miscellaneous Rheumatic and Inflammatory Diseases

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 8, 2021

Title: Abstracts: Miscellaneous Rheumatic & Inflammatory Diseases: New Insights into Therapies & Mechanisms of Disease (1452–1457)

Session Type: Abstract Session

Session Time: 4:15PM-4:30PM

Background/Purpose: Relapsing polychondritis (RP) is an inflammatory disorder that affects cartilage of ears, nose, joints, and respiratory tract. The inflammation often spreads to eyes, cardiovascular system, inner ears, skin, and CNS. Previous studies of RP disclosed that mononuclear cells migrated into the perichondral tissues and adjacent chondrocytes produced matrix metalloproteinase (MMP)-3. We found that serum MMP3 concentrations were significantly higher in RP patients, especially in patients with respiratory involvement, than healthy individuals (HI). In the current study, we investigate whether serum MMP3 associate with inflammatory cytokine mRNA expressions of peripheral blood mononuclear cells (PBMC) in RP patients with a focus on the incidence and severity of the complications.

Methods: We obtained sera and PBMC from 30 RP patients and age and gender matched 14 HI. We divided the patients into two subgroups, that is, those with airway involvement (respiratory subgroup, 16 patients) and those without airway involvement (non-respiratory subgroup, 14 patients). We measured mRNA expressions of IL1β, IL6, TNFα, and MMP3, in freshly isolated, 6-hour-cultured, and 24-hour-cultured PBMC. We collected time series data of serum MMP3 and cytokine gene expressions from 6 RP patients (follow-up, mean ± sem., 34 ± 7.0 months) and 6 HI (45 ± 0.2 months).

Results: Inflammatory cytokine mRNA expressions of freshly isolated PBMC were significantly lower in RP patients than those in HI. IL1β and MMP3 mRNA expressions of 24-hour-cultured PBMC were significantly higher in RP patients than those in HI. Serum MMP3 increased significantly in respiratory subgroup compared with those in non-respiratory subgroup. Serum MMP3 and mRNA expressions of IL1β and IL6 showed positive linear correlations in 6-hour- and 24-hour-cultured PBMC of respiratory subgroup, but not those in non-respiratory subgroup. Linear correlations were found between serum MMP3 and PBMC MMP3 mRNA in both respiratory and non-respiratory subgroups. A linear correlation was observed between serum MMP3 and RPDAI in non-respiratory subgroup but not in respiratory subgroup. The time series study suggests that serum MMP3 and IL1β mRNA expressions of 6-hour-cultured PBMC were higher in RP patients than those in HI at least for several years (39 ± 3.7 months).

Conclusion: It is possible that IL1β has a potential to induce efficiently immune responses of RP cartilaginous tissues in the airway tract using MMP3. RPDAI may be more sensitive for the evaluation of disease status in non-respiratory subgroup than that in respiratory subgroup. RP PBMC may have a characteristic for persisting their dysregulated immune responses for a long time.


Disclosures: J. Shimizu, None; S. Wakisaka, None; T. Suzuki, None; N. Suzuki, None.

To cite this abstract in AMA style:

Shimizu J, Wakisaka S, Suzuki T, Suzuki N. IL1β mRNA Expressions in Peripheral Blood Mononuclear Cells Increase and May Associate with Cartilage Damage of the Respiratory Tract Probably Through Matrix metalloproteinase-3 Production in Patients with Relapsing Polychondritis [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/il1%ce%b2-mrna-expressions-in-peripheral-blood-mononuclear-cells-increase-and-may-associate-with-cartilage-damage-of-the-respiratory-tract-probably-through-matrix-metalloproteinase-3-production-in-pat/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/il1%ce%b2-mrna-expressions-in-peripheral-blood-mononuclear-cells-increase-and-may-associate-with-cartilage-damage-of-the-respiratory-tract-probably-through-matrix-metalloproteinase-3-production-in-pat/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology